These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

76 related articles for article (PubMed ID: 4368656)

  • 1. Effects of ACTH on the sleep of normal subjects and patients with Addison's disease.
    Gillin JC; Jacobs LS; Snyder F; Henkin RI
    Neuroendocrinology; 1974; 15(1):21-31. PubMed ID: 4368656
    [No Abstract]   [Full Text] [Related]  

  • 2. Glucocorticoid replacement is permissive for rapid eye movement sleep and sleep consolidation in patients with adrenal insufficiency.
    García-Borreguero D; Wehr TA; Larrosa O; Granizo JJ; Hardwick D; Chrousos GP; Friedman TC
    J Clin Endocrinol Metab; 2000 Nov; 85(11):4201-6. PubMed ID: 11095454
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Acutely raised corticotropin levels in Addison's disease are not associated with increased plasma arginine vasopressin and corticotropin-releasing factor concentrations in peripheral plasma.
    Wittert GA; Livesey JH; Florkowski C; Or HK; Donald RA; Espiner EA
    J Clin Endocrinol Metab; 1993 Jan; 76(1):192-6. PubMed ID: 8380605
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Adrenocorticotropic hormone receptor-blocking immunoglobulins in serum from patients with Addison's disease: a reexamination.
    Wardle CA; Weetman AP; Mitchell R; Peers N; Robertson WR
    J Clin Endocrinol Metab; 1993 Sep; 77(3):750-3. PubMed ID: 8396577
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The nature of the circadian periodicity and suppressibility of immunoreactive ACTH levels in Addison's disease.
    Krieger DT; Gewirtz GP
    J Clin Endocrinol Metab; 1974 Jul; 39(1):46-52. PubMed ID: 4365917
    [No Abstract]   [Full Text] [Related]  

  • 6. Does recovery of adrenal function occur in patients with autoimmune Addison's disease?
    Smans LC; Zelissen PM
    Clin Endocrinol (Oxf); 2011 Apr; 74(4):434-7. PubMed ID: 21114513
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Suppression of plasma ACTH levels with corticosteroids in Addison's disease.
    Holdaway IM
    Clin Endocrinol (Oxf); 1973 Jan; 2(1):37-42. PubMed ID: 4358776
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adrenal response to ACTH administration in normal subjects, in patients with Addison's disease and in patients chronically treated with steroids (author's transl)].
    Arteaga E; López JM; Godoy R; Silva R
    Rev Med Chil; 1980 Feb; 108(2):109-11. PubMed ID: 6264560
    [No Abstract]   [Full Text] [Related]  

  • 9. Loperamide modifies but does not block the corticotropin-releasing hormone-induced ACTH response in patients with Addison's disease.
    Ambrosi B; Bochicchio D; Colombo P; Ferrario R; Faglia G
    Horm Metab Res Suppl; 1987; 16():74-5. PubMed ID: 2832297
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [State of the cardiovascular system in patients with Addison's disease].
    Viazitskiĭ PO; Sergeev AI
    Kardiologiia; 1970 Jan; 10(1):135-9. PubMed ID: 4314344
    [No Abstract]   [Full Text] [Related]  

  • 11. A short negative feedback mechanism regulating corticotropin-releasing hormone release.
    Suda T; Tomori N; Yajima F; Ushiyama T; Sumitomo T; Nakagami Y; Demura H; Shizume K
    J Clin Endocrinol Metab; 1987 May; 64(5):909-13. PubMed ID: 3031120
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Study of mineralo-corticoid function in Addison's disease; apropos of 10 cases].
    Schaison G; Sebaoun J; Delzant G; Gilbert-Dreyfus
    Ann Endocrinol (Paris); 1970; 31(4):609-23. PubMed ID: 4322611
    [No Abstract]   [Full Text] [Related]  

  • 13. Probable pituitary adenoma with adrenocorticotropin hypersecretion (corticotropinoma) secondary to Addison's disease.
    Jara-Albarran A; Bayort J; Caballero A; Portillo J; Laborda L; Sampedro M; Cure C; Mateos JM
    J Clin Endocrinol Metab; 1979 Aug; 49(2):236-41. PubMed ID: 222793
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evidence against a self-inhibition of ACTH secretion in man.
    Cavagnini F; Invitti C; Danesi L; Passamonti M; Fossati R
    Neuroendocrinology; 1985 Dec; 41(6):518-25. PubMed ID: 3001562
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Influences of corticotropin-releasing hormone, adrenocorticotropin, and cortisol on sleep in normal man.
    Born J; Späth-Schwalbe E; Schwakenhofer H; Kern W; Fehm HL
    J Clin Endocrinol Metab; 1989 May; 68(5):904-11. PubMed ID: 2541159
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Growth hormone secretion in Addison's disease.
    Crabbé J; Henquin JC; Lambert AE
    Ann Endocrinol (Paris); 1978; 39(2):165-6. PubMed ID: 210706
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent hypersecretion of ACTH in treated Addison's disease.
    Child DF; Lewis F; Williams CP
    J R Soc Med; 1990 Jun; 83(6):399-400. PubMed ID: 2166161
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunoglobulins of patients with idiopathic Addison's disease block the in vitro action of adrenocorticotropin.
    Wulffraat NM; Drexhage HA; Bottazzo GF; Wiersinga WM; Jeucken P; Van der Gaag R
    J Clin Endocrinol Metab; 1989 Aug; 69(2):231-8. PubMed ID: 2546959
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Problems of physiopathology and diagnosis in Addison's disease].
    Milcu SM; Stan M; Mănciulescu D
    Stud Cercet Endocrinol; 1968; 19(5):335-79. PubMed ID: 4304598
    [No Abstract]   [Full Text] [Related]  

  • 20. Adrenocortical response to ACTH in Addison's disease.
    Tyler FH
    N Engl J Med; 1973 Apr; 288(16):854-5. PubMed ID: 4348411
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.